_________________
February 6, 2024 | Amaris Consulting provides high value-added technology services in the digital and information systems, telecommunications, life sciences and engineering fields for over 1,000 clients across the globe.
Trinity Bridge Professional Services LLC, a life sciences consulting firm in New England, have partnered to extend a suite of digital validation solutions from ValGenesis to help companies in the U.S. respond rapidly to increasingly dynamic environments.
In this partnership, Performance Validation will implement and manage next-generation digital validation tools developed by ValGenesis, including ValGenesis VLMS and VLMS Express, a simplified cloud-based digital validation solution for startups and midsized companies.
MMR Consulting will implement and support the ValGenesis product suite, including ValGenesis VLMS, and VLMS Express, a simplified cloud-based validation solution for organizations that need to start small and deploy and scale quickly
ValGenesis and GMP Pros aim to help customers solve their most complex process challenges and meet their digital compliance obligations through a suite of versatile products from ValGenesis.
Founded in Spain over eight decades ago, the company focuses on developing over the counter (OTC) drugs and products. Since then, it has grown its production to include prescription (RX) drugs and launched its first generic product on the Spanish market.
ValGenesis and Medhini are working to enable customers with robust manufacturing intelligence solutions from ValGenesis – VLMS, iRisk, Process Manager, Process Insight, and e-Logbook.
AmplifyBio is growing rapidly in the pursuit of creating the leading technology-integrated service organization for the commercialization of advanced therapies.
Acumen Analytics, a leader in intelligent digital transformation, have partnered to provide advanced risk management solutions for life sciences companies.
ValGenesis digital validation platform was chosen to enhance their global validation processes, underscoring its commitment to elevating CAR-T therapy production standards.